EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mycoplasma genitalium

Oluyomi A Obafemi, Sarah E Rowan, Masayo Nishiyama, Karen A Wendel

Medical Clinics of North America · 2024

DOI: 10.1016/j.mcna.2023.07.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Clinics of North America, 2024. Verfasst von Oluyomi A Obafemi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Institute at Denver Health, 601 Broadway, 8th Floor, MC 2800, Denver, CO 80203-3407, USA; Department of Family Medicine, University of …. Hauptthemen laut MEDLINE: Urethritis, Mycoplasma genitalium, Uterine Cervicitis, Mycoplasma Infections. Die Arbeit nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycoplasma genitalium (MG) is an emerging sexually transmitted infection, which appears to be a cause of urethritis and cervicitis and has been associated with pelvic inflammatory disease (PID), epididymitis, proctitis, infertility, complications during pregnancy, and human immunodeficiency virus (HIV) transmission. Three Food and Drug Administration (FDA) approved tests are available. Testing should be focused to avoid inappropriate antibiotic use. The Center of Disease Control and Prevention (CDC) guidelines recommend testing for persistent male urethritis, cervicitis, and proctitis and state that testing should be considered in cases of PID. Testing is also recommended for sexual contacts of patients with MG. Testing is not recommended in asymptomatic patients, including pregnant patients, who do not have a history of MG exposure. Although resistance-guided therapy is recommended, there are currently no FDA approved tests for MG macrolide resistance, and tests are not widely available in the United States. The CDC recommends 2-step treatment with doxycycline followed by azithromycin or moxifloxacin. Moxifloxacin is recommended if resistance testing is unavailable or testing demonstrates macrolide resistance..

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UrethritisMycoplasma genitaliumUterine CervicitisMycoplasma InfectionsPelvic Inflammatory DiseaseProctitisPregnancyFemaleHumansMaleAnti-Bacterial AgentsMoxifloxacinMacrolidesDrug Resistance, BacterialPrimary Health Care

Stichwörter der Autor:innen

Antimicrobial resistanceCervicitisFluoroquinoloneMacrolideMycoplasma genitaliumNucleic acid amplification testUrethritis

Substanzen

Anti-Bacterial AgentsMoxifloxacinMacrolides

Autor:innen und Institutionen

  • Public Health Institute at Denver Health, 601 Broadway, 8th Floor, MC 2800, Denver, CO 80203-3407, USA; Department of Family Medicine, University of Colorado Denver, Aurora, CO, USA.
  • Public Health Institute at Denver Health, 601 Broadway, 8th Floor, MC 2800, Denver, CO 80203-3407, USA; Division of Infectious Diseases, Department of Medicine, University of Colorado Denver, Aurora, CO, USA.
  • Public Health Institute at Denver Health, 601 Broadway, 8th Floor, MC 2800, Denver, CO 80203-3407, USA.
  • Public Health Institute at Denver Health, 601 Broadway, 8th Floor, MC 2800, Denver, CO 80203-3407, USA; Division of Infectious Diseases, Department of Medicine, University of Colorado Denver, Aurora, CO, USA. Electronic…

Zitieren

APA

Obafemi, O. A., Rowan, S. E., Nishiyama, M., & Wendel, K. A. (2024). Mycoplasma genitalium. Medical Clinics of North America. https://doi.org/10.1016/j.mcna.2023.07.004

Vancouver

Obafemi OA, Rowan SE, Nishiyama M, Wendel KA. Mycoplasma genitalium. Medical Clinics of North America. 2024. doi:10.1016/j.mcna.2023.07.004

BibTeX
@article{Obafemi2024,
  author = {Obafemi, Oluyomi A and Rowan, Sarah E and Nishiyama, Masayo and Wendel, Karen A},
  title = {Mycoplasma genitalium},
  journal = {Medical Clinics of North America},
  year = {2024},
  doi = {10.1016/j.mcna.2023.07.004}
}
Kostenlos starten →